Proteomics mining of cancer hallmarks on a single‐cell resolution
Mass Spectrometry Reviews · 2024
DOI: 10.1002/mas.21842 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, 2024. Verfasst von Maomao Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE and State Key Laboratory o…. Hauptthemen laut MEDLINE: Proteomics, Single-Cell Analysis, Neoplasms, Mass Spectrometry. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 160 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Project, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Dysregulated proteome is an essential contributor in carcinogenesis. Protein fluctuations fuel the progression of malignant transformation, such as uncontrolled proliferation, metastasis, and chemo/radiotherapy resistance, which severely impair therapeutic effectiveness and cause disease recurrence and eventually mortality among cancer patients. Cellular heterogeneity is widely observed in cancer and numerous cell subtypes have been characterized that greatly influence cancer progression. Population‐averaged research may not fully reveal the heterogeneity, leading to inaccurate conclusions. Thus, deep mining of the multiplex proteome at the single‐cell resolution will provide new insights into cancer biology, to develop prognostic biomarkers and treatments. Considering the recent advances in single‐cell proteomics, herein we review several novel technologies with particular focus on single‐cell mass spectrometry analysis, and summarize their advantages and practical applications in the diagnosis and treatment for cancer. Technological development in single‐cell proteomics will bring a paradigm shift in cancer detection, intervention, and therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE and State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan Universit…
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University and Collaborative Innovation Center for Biotherapy, Chen…
- Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Project
- Guangdong Basic and Applied Basic Research Foundation
- the Key Research Programs of Science and Technology Department of Sichuan Province
- Sichuan Science-Technology International Cooperation Project
Zitieren
APA
Li, M., Zuo, J., Yang, K., Wang, P., & Zhou, S. (2024). Proteomics mining of cancer hallmarks on a single‐cell resolution. Mass Spectrometry Reviews. https://doi.org/10.1002/mas.21842
Vancouver
Li M, Zuo J, Yang K, Wang P, Zhou S. Proteomics mining of cancer hallmarks on a single‐cell resolution. Mass Spectrometry Reviews. 2024. doi:10.1002/mas.21842
BibTeX
@article{Li2024,
author = {Li, Maomao and Zuo, Jing and Yang, Kailin and Wang, Ping and Zhou, Shengtao},
title = {Proteomics mining of cancer hallmarks on a single‐cell resolution},
journal = {Mass Spectrometry Reviews},
year = {2024},
doi = {10.1002/mas.21842}
}
EUVIMED